Cargando…

Anosmia and dysgeusia as markers of severity and prognosis in COVID-19

Detalles Bibliográficos
Autores principales:	Carpio-Orantes, Luis Del, Garcia-Mendez, Sergio, Diaz, Jesus Salvador Sanchez, Solis-Sanchez, Ishar, Aguilar-Silva, Andres
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158657/ https://www.ncbi.nlm.nih.gov/pubmed/37151791 http://dx.doi.org/10.4103/bc.bc_65_22

Ejemplares similares

Neurological symptoms in patients with COVID-19 as manifestation of severity and prognosis, the case of anosmia and dysgeusia
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2021)

Incidence of stroke in a population affected by COVID-19 in Veracruz, México
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia
por: Eshraghi, Adrien A., et al.
Publicado: (2020)

Anosmia and dysgeusia in COVID-19: A systematic review
por: Carrillo-Larco, Rodrigo M., et al.
Publicado: (2020)

Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
por: Zayet, Souheil, et al.
Publicado: (2020)

Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
por: Zahra, Syeda Anum, et al.
Publicado: (2020)

Guillain–Barré syndrome associated with vaccines in Veracruz, Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2022)

Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic
por: Krishnakumar, Hari N., et al.
Publicado: (2022)

Stellate Ganglion Block for Anosmia and Dysgeusia Due to Long COVID
por: Chauhan, Gaurav, et al.
Publicado: (2022)

Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019
por: Lee, Daniel J., et al.
Publicado: (2020)

Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?
por: Lorenzo Villalba, Noel, et al.
Publicado: (2020)

Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection
por: Lao, Wilson P., et al.
Publicado: (2020)

Transient Anosmia and Dysgeusia in COVID-19 Disease: A Cross Sectional Study
por: Ali, Fatema Ahmed, et al.
Publicado: (2023)

Guillain-Barré Syndrome, Before and After Zika
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2019)

Guillain-Barré syndrome, from the search for Zika to the discovery of asymptomatic campylobacteriosis as a risk factor for neurological syndromes in Veracruz, Mexico
por: Carpio-Orantes, Luis Del
Publicado: (2022)

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients()
por: Singh, Chandra Veer, et al.
Publicado: (2021)

Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
por: Alharbi, Hamad, et al.
Publicado: (2021)

Neuropsychiatric manifestations in patients with long COVID in Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Sudden onset anosmia and dysgeusia in two patients: An early sign of SARS-CoV-2 infection
por: Alamri, Ahmad, et al.
Publicado: (2020)

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients
por: Singh, Chandra Veer, et al.
Publicado: (2021)

1680. Guillain Barré Syndrome in Arbovirus Outbreak in Veracruz, Mexico: The Follow-up to 3 Years of the Pandemic
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2019)

Risk Factors for Persistent Anosmia and Dysgeusia in Children with SARS-CoV-2 Infection: A Retrospective Study
por: Mariani, Francesco, et al.
Publicado: (2023)

Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients”
por: Verma, Ravneet Ravinder, et al.
Publicado: (2021)

Teorías del long COVID entrelazadas para explicar su etiopatogenia
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2023)

Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis
por: Mutiawati, Endang, et al.
Publicado: (2021)

Dysosmia and dysgeusia associated with duloxetine
por: Yoshida, Katsuyuki, et al.
Publicado: (2017)

COVID-19 and dengue coinfection in Veracruz, Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2022)

Campylobacter: Asymptomatic campylobacteriosis and Guillain Barré syndrome in Mexico
por: Del Carpio-Orantes, Luis
Publicado: (2022)

Etiopathogenic theories about long COVID
por: Del Carpio-Orantes, Luis
Publicado: (2023)

Complementos “herbolarios” expandiéndose maliciosamente desde México para el mundo. Artriking y compañía
por: Del Carpio Orantes, Luis
Publicado: (2023)

Propuesta de abordaje diagnóstico del COVID persistente
por: Del Carpio-Orantes, Luis
Publicado: (2023)

Zinc Deficiency-Associated Dysgeusia Preventing the Improvement of Severe Hyperemesis Gravidarum
por: Tanabe, Shohei, et al.
Publicado: (2022)

Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review
por: Spencer, Ana Sofia, et al.
Publicado: (2021)

1114. Comparative analysis between Polymerized Type I Collagen and Baricitinib as potential treatment for COVID-19
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2022)

Dysgeusia in COVID-19: Possible Mechanisms and Implications
por: Lozada-Nur, Francina, et al.
Publicado: (2020)

Dysgeusia: A review in the context of COVID-19
por: Thomas, Davis C., et al.
Publicado: (2022)

396. Clinical Characterization of Long COVID in Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2023)

520. Polymerized type I collagen as a treatment for COVID-19 in Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2023)

Anosmia: A marker of infection by the new corona virus
por: Daher, Valéria Barcelos, et al.
Publicado: (2020)

Anosmia and ageusia
por: Tarakji, B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ittjn70r9noisbfmt42e77i5pv